Marc Scheineson will be a panelist at this webinar hosted by the Regulatory Affairs Professionals Society (RAPS). This virtual program will feature presentations and a panel discussion with decades of experience working for and with FDA, followed by an opportunity for attendees to ask questions.
The Biden administration has brought in new policies and personnel to the federal health care team. The FDA remains in the news every day as it exercises its vast responsibilities over drugs and devices. At the same time, the FDA must restore its reputation, show that it has learned from the pandemic, manage some of the most challenging issues and decisions it has ever faced, and be prepared to effect still further changes.
For more information, click here.